Table of Contents
1. Executive Summary
2. Industry Introduction, including Taxonomy and Market Definition
3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, including Historical Analysis and Future Projections
5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034
- 5.1. Drug Class
- 5.2. Indication
- 5.3. Route of Administration
- 5.4. Distribution Channel
6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Drug Class
- 6.1. Thrombopoietin Receptor Agonists (TRAs)
- 6.2. Proteasome Inhibitors
- 6.3. Erythropoiesis-Stimulating Agents (ESAs)
- 6.4. Granulocyte Colony-Stimulating Factors (G-CSFs)
- 6.5. Other Peptide Therapeutics
7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Indication
- 7.1. Thrombocytopenia
- 7.2. Multiple Myeloma
- 7.3. Anemia
- 7.4. Neutropenia
- 7.5. Hemophilia
- 7.6. Sickle Cell Anemia
- 7.7. Leukemia and Lymphoma
- 7.8. Others
8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Route of Administration
- 8.1. Injectable
- 8.2. Oral
9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Distribution Channel
- 9.1. Hospital Pharmacies
- 9.2. Retail Pharmacies
- 9.3. Specialty Pharmacies
- 9.4. Online Pharmacies
10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
- 10.1. North America
- 10.2. Latin America
- 10.3. Europe
- 10.4. Asia Pacific
- 10.5. Middle East & Africa
11. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
12. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
13. Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
14. Asia Pacific Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
15. Middle East & Africa Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
16. Sales Forecast 2024 to 2034 by Drug Class, Indication, Route of Administration, and Distribution Channel for 30 Countries
17. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
18. Company Profile
- 18.1. Amgen, Inc.
- 18.2. Johnson & Johnson (Janssen Pharmaceuticals)
- 18.3. Roche (Chugai Pharmaceutical)
- 18.4. Novartis AG
- 18.5. Sanofi S.A.
- 18.6. Pfizer, Inc.
- 18.7. Takeda Pharmaceutical Company
- 18.8. Eli Lilly and Company
- 18.9. Biogen, Inc.
- 18.10. GlaxoSmithKline (GSK)
- 18.11. Bristol Myers Squibb Company
- 18.12. AbbVie Inc.
- 18.13. Merck & Co., Inc.
- 18.14. AstraZeneca
- 18.15. Alexion Pharmaceuticals (AstraZeneca subsidiary)
List of Tables
Table 1: Global Market Value (US$ Mn) Forecast by Region, 2019 to 2034
Table 2: Global Market Value (US$ Mn) Forecast by Drug Class, 2019 to 2034
Table 3: Global Market Value (US$ Mn) Forecast by Indication, 2019 to 2034
Table 4: Global Market Value (US$ Mn) Forecast by Route of Administration, 2019 to 2034
Table 5: Global Market Value (US$ Mn) Forecast by Distribution Channel, 2019 to 2034
Table 6: North America Market Value (US$ Mn) Forecast by Country, 2019 to 2034
Table 7: North America Market Value (US$ Mn) Forecast by Drug Class, 2019 to 2034
Table 8: North America Market Value (US$ Mn) Forecast by Indication, 2019 to 2034
Table 9: North America Market Value (US$ Mn) Forecast by Route of Administration, 2019 to 2034
Table 10: North America Market Value (US$ Mn) Forecast by Distribution Channel, 2019 to 2034
Table 11: Latin America Market Value (US$ Mn) Forecast by Country, 2019 to 2034
Table 12: Latin America Market Value (US$ Mn) Forecast by Drug Class, 2019 to 2034
Table 13: Latin America Market Value (US$ Mn) Forecast by Indication, 2019 to 2034
Table 14: Latin America Market Value (US$ Mn) Forecast by Route of Administration, 2019 to 2034
Table 15: Latin America Market Value (US$ Mn) Forecast by Distribution Channel, 2019 to 2034
Table 16: Europe Market Value (US$ Mn) Forecast by Country, 2019 to 2034
Table 17: Europe Market Value (US$ Mn) Forecast by Drug Class, 2019 to 2034
Table 18: Europe Market Value (US$ Mn) Forecast by Indication, 2019 to 2034
Table 19: Europe Market Value (US$ Mn) Forecast by Route of Administration, 2019 to 2034
Table 20: Europe Market Value (US$ Mn) Forecast by Distribution Channel, 2019 to 2034
Table 21: Asia Pacific Market Value (US$ Mn) Forecast by Country, 2019 to 2034
Table 22: Asia Pacific Market Value (US$ Mn) Forecast by Drug Class, 2019 to 2034
Table 23: Asia Pacific Market Value (US$ Mn) Forecast by Indication, 2019 to 2034
Table 24: Asia Pacific Market Value (US$ Mn) Forecast by Route of Administration, 2019 to 2034
Table 25: Asia Pacific Market Value (US$ Mn) Forecast by Distribution Channel, 2019 to 2034
Table 26: Middle East & Africa Market Value (US$ Mn) Forecast by Country, 2019 to 2034
Table 27: Middle East & Africa Market Value (US$ Mn) Forecast by Drug Class, 2019 to 2034
Table 28: Middle East & Africa Market Value (US$ Mn) Forecast by Indication, 2019 to 2034
Table 29: Middle East & Africa Market Value (US$ Mn) Forecast by Route of Administration, 2019 to 2034
Table 30: Middle East & Africa Market Value (US$ Mn) Forecast by Distribution Channel, 2019 to 2034
List of Figures
Figure 1: Global Market Value Share (%), Growth Rate (Y-o-Y), and Value (US$ Mn) Projection by Drug Class, 2019 to 2034
Figure 2: Global Market Value Share (%), Growth Rate (Y-o-Y), and Value (US$ Mn) Projection by Indication, 2019 to 2034
Figure 3: Global Market Value Share (%), Growth Rate (Y-o-Y), and Value (US$ Mn) Projection by Route of Administration, 2019 to 2034
Figure 4: Global Market Value Share (%), Growth Rate (Y-o-Y), and Value (US$ Mn) Projection by Distribution Channel, 2019 to 2034
Figure 5: Global Market Value Share (%), Growth Rate (Y-o-Y), and Value (US$ Mn) Projection by Region, 2019 to 2034
Figure 6: North America Market Value Share (%), Growth Rate (Y-o-Y), and Value (US$ Mn) Projection by Drug Class, 2019 to 2034
Figure 7: North America Market Value Share (%), Growth Rate (Y-o-Y), and Value (US$ Mn) Projection by Indication, 2019 to 2034
Figure 8: North America Market Value Share (%), Growth Rate (Y-o-Y), and Value (US$ Mn) Projection by Route of Administration, 2019 to 2034
Figure 9: North America Market Value Share (%), Growth Rate (Y-o-Y), and Value (US$ Mn) Projection by Distribution Channel, 2019 to 2034
Figure 10: North America Market Value Share (%), Growth Rate (Y-o-Y), and Value (US$ Mn) Projection by Country, 2019 to 2034
Figure 11: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and Value (US$ Mn) Projection by Drug Class, 2019 to 2034
Figure 12: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and Value (US$ Mn) Projection by Indication, 2019 to 2034
Figure 13: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and Value (US$ Mn) Projection by Route of Administration, 2019 to 2034
Figure 14: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and Value (US$ Mn) Projection by Distribution Channel, 2019 to 2034
Figure 15: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and Value (US$ Mn) Projection by Country, 2019 to 2034
Figure 16: Europe Market Value Share (%), Growth Rate (Y-o-Y), and Value (US$ Mn) Projection by Drug Class, 2019 to 2034
Figure 17: Europe Market Value Share (%), Growth Rate (Y-o-Y), and Value (US$ Mn) Projection by Indication, 2019 to 2034
Figure 18: Europe Market Value Share (%), Growth Rate (Y-o-Y), and Value (US$ Mn) Projection by Route of Administration, 2019 to 2034
Figure 19: Europe Market Value Share (%), Growth Rate (Y-o-Y), and Value (US$ Mn) Projection by Distribution Channel, 2019 to 2034
Figure 20: Europe Market Value Share (%), Growth Rate (Y-o-Y), and Value (US$ Mn) Projection by Country, 2019 to 2034
Figure 21: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and Value (US$ Mn) Projection by Drug Class, 2019 to 2034
Figure 22: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and Value (US$ Mn) Projection by Indication, 2019 to 2034
Figure 23: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and Value (US$ Mn) Projection by Route of Administration, 2019 to 2034
Figure 24: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and Value (US$ Mn) Projection by Distribution Channel, 2019 to 2034
Figure 25: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and Value (US$ Mn) Projection by Country, 2019 to 2034
Figure 26: Middle East & Africa Market Value Share (%), Growth Rate (Y-o-Y), and Value (US$ Mn) Projection by Drug Class, 2019 to 2034
Figure 27: Middle East & Africa Market Value Share (%), Growth Rate (Y-o-Y), and Value (US$ Mn) Projection by Indication, 2019 to 2034
Figure 28: Middle East & Africa Market Value Share (%), Growth Rate (Y-o-Y), and Value (US$ Mn) Projection by Route of Administration, 2019 to 2034
Figure 29: Middle East & Africa Market Value Share (%), Growth Rate (Y-o-Y), and Value (US$ Mn) Projection by Distribution Channel, 2019 to 2034
Figure 30: Middle East & Africa Market Value Share (%), Growth Rate (Y-o-Y), and Value (US$ Mn) Projection by Country, 2019 to 2034
Who worked on this report
Preview the report firsthand - request a free sample
Free SampleGet the brochure for pricing and purchase details
Download PDF